Schizophrenia
Item
participants who are diagnosed with schizophrenia (according to diagnostic and statistical manual of mental disorders [edition 4] criteria)
boolean
C0036341 (UMLS CUI [1])
Clinical global impression scale
Item
participants with clinical global impression-severity (cgi-s) score greater than or equal to 4 points (moderately ill) at screening
boolean
C3639708 (UMLS CUI [1])
Childbearing Potential Contraceptive methods | Oral contraception | Contraceptive injection | Intrauterine Devices | Barrier Contraception Double | Contraceptive patch
Item
childbearing potential women who consented to the consistent use of the acceptable contraception (oral contraceptive, contraceptive injection, intrauterine device, double barrier method and contraceptive patch)
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0029151 (UMLS CUI [2])
C1656586 (UMLS CUI [3])
C0021900 (UMLS CUI [4])
C0004764 (UMLS CUI [5,1])
C0205173 (UMLS CUI [5,2])
C2985284 (UMLS CUI [6])
Questionnaire Completion Self
Item
participants who are capable of and willing to fill out the questionnaire for themselves
boolean
C0034394 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0036588 (UMLS CUI [1,3])
Compliance behavior Self Medication | Ability Receive Support
Item
participants who are compliant with self-medication or can receive consistent help or support
boolean
C1321605 (UMLS CUI [1,1])
C0036600 (UMLS CUI [1,2])
C0085732 (UMLS CUI [2,1])
C1514756 (UMLS CUI [2,2])
C1521721 (UMLS CUI [2,3])
Neuroleptic Malignant Syndrome | High fever | Muscle Rigidity | Tremor | Confusion | Increased sweating | Tachycardia | Hypertensive disease | Myalgia | Weakness
Item
participants with the past history of neuroleptic malignant syndrome (high fever, rigid muscles, shaking, confusion, sweating more than usual, increased heart rate or blood pressure, or muscle pain or weakness)
boolean
C0027849 (UMLS CUI [1])
C0743973 (UMLS CUI [2])
C0026837 (UMLS CUI [3])
C0040822 (UMLS CUI [4])
C0009676 (UMLS CUI [5])
C0700590 (UMLS CUI [6])
C0039231 (UMLS CUI [7])
C0020538 (UMLS CUI [8])
C0231528 (UMLS CUI [9])
C3714552 (UMLS CUI [10])
Risperidone allergy | Hypersensitivity Paliperidone
Item
participants with allergy or hypersensitivity to risperidone or paliperidone
boolean
C0570837 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0753678 (UMLS CUI [2,2])
Clozapine | Exposure to Investigational New Drugs
Item
participants who have taken clozapine, or have been exposed to the study drug within one month before screening
boolean
C0009079 (UMLS CUI [1])
C0332157 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
Injection of depot antipsychotic agent
Item
participants who have been treated with the long acting antipsychotic injection within 28 days
boolean
C2585377 (UMLS CUI [1])
Study Subject At risk | At risk for suicide | At risk Aggressive behavior
Item
participants with significant risk including suicide or aggressive behavior
boolean
C0681850 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0563664 (UMLS CUI [2])
C1444641 (UMLS CUI [3,1])
C0001807 (UMLS CUI [3,2])